About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Active Not RecruitingPhase 4

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV: A Prospective, Individual, Double-Blind, Randomized Controlled Study.

NCT06436274•Massachusetts General Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Human Papilloma VirusHiv

Interventions

GARDASIL®9

Menveo®/Menactra®

Locations

3

Botswana

Locations (3)

Botswana Harvard Health Partnership

Gaborone, Botswana

Ministry of Health and Center for Family Health Research

Kigali, Kigali, Rwanda

Wits RHI, University of the Witwatersrand

Johannesburg, Gauteng, South Africa

Key Dates

Start Date

October 14, 2024

Primary Completion Date

December 1, 2026

Completion Date

June 1, 2027

Last Updated

January 12, 2026

Related Studies

Thinking and Memory Problems in People With HIV

NCT01875588

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

NCT06857071

Undiagnosed HIV InfectionPopulations That Are Reluctant to Test for HIV+4 more

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397

Human Immunodeficiency Virus (HIV)Smoking Cessation

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764

Substance AbuseIntimate Partner Violence (IPV)+3 more

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

NCT07509853

HIV PreventionSubstance Use+3 more

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study

NCT07512869

HIV PreventionSubstance Use+2 more

View all related studies

Sponsors

Lead Sponsor

Massachusetts General Hospital

Collaborators

University of Witwatersrand, South Africa
Botswana Harvard Health Partnership
Ministry of Health, Rwanda
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Karolinska Institutet

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 12, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions